Effect of combining ACE inhibitor and statin in lupus-prone mice.

[1]  R. Nagai,et al.  Inhibition of renin-angiotensin system attenuates periadventitial inflammation and reduces atherosclerotic lesion formation. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  M. Menger,et al.  Simvastatin protects against cholestasis‐induced liver injury , 2009, British journal of pharmacology.

[3]  L. Steinman,et al.  Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[4]  K. Kinoshita,et al.  The beneficial effects of treatment with all‐trans‐retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF1 mice , 2005, Clinical and experimental immunology.

[5]  M. Ehrenstein,et al.  Atorvastatin Inhibits Autoreactive B Cell Activation and Delays Lupus Development in New Zealand Black/White F1 Mice1 , 2004, The Journal of Immunology.

[6]  K. Kinoshita,et al.  Blockade of IL-18 Receptor Signaling Delays the Onset of Autoimmune Disease in MRL-Faslpr Mice1 , 2004, The Journal of Immunology.

[7]  B. Jeppsson,et al.  Critical role of CXC chemokines in endotoxemic liver injury in mice , 2004, Journal of leukocyte biology.

[8]  G. Boivin,et al.  An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis , 2004 .

[9]  C. Cohen,et al.  Angiotensin Inhibition Reduces Glomerular Damage and Renal Chemokine Expression in MRL/lpr Mice , 2003, Journal of Pharmacology and Experimental Therapeutics.

[10]  Yuji Nozaki,et al.  Retinoic Acid Reduces Autoimmune Renal Injury and Increases Survival in NZB/W F1 Mice , 2003, The Journal of Immunology.

[11]  G. Remuzzi,et al.  Effect of combining ACE inhibitor and statin in severe experimental nephropathy. , 2002, Kidney international.

[12]  A. Mantovani,et al.  Inhibition of Monocyte Chemotactic Protein-1 Synthesis by Statins , 2000, Laboratory Investigation.

[13]  T. Awata,et al.  Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells. , 2000, Life sciences.

[14]  Shokei Kim,et al.  Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. , 2000, Pharmacological reviews.

[15]  B. Rollins,et al.  Monocyte Chemoattractant Protein 1–Dependent Leukocytic Infiltrates Are Responsible for Autoimmune Disease in Mrl-Faslpr Mice , 1999, The Journal of experimental medicine.

[16]  A. Schwarting,et al.  IFN-gamma receptor signaling is essential for the initiation, acceleration, and destruction of autoimmune kidney disease in MRL-Fas(lpr) mice. , 1998, Journal of immunology.

[17]  J. Egido,et al.  Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. , 1998, Journal of immunology.

[18]  D. Balomenos,et al.  Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. , 1998, The Journal of clinical investigation.

[19]  J. Moslehi,et al.  Roles of interferon-gamma and interleukin-4 in murine lupus. , 1997, The Journal of clinical investigation.

[20]  A. Theofilopoulos,et al.  Etiopathogenesis of Murine SLE 1 , 1981 .

[21]  Chul-woo Yang,et al.  Pravastatin treatment attenuates interstitial inflammation and fibrosis in a rat model of chronic cyclosporine-induced nephropathy. , 2004, American journal of physiology. Renal physiology.

[22]  M. Ehrenstein,et al.  Activation and Delays Lupus Development in Atorvastatin Inhibits Autoreactive B Cell , 2004 .

[23]  B. Rollins,et al.  Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. , 1999, The Journal of clinical investigation.

[24]  B. Kasiske,et al.  Lovastatin inhibits proliferation of rat mesangial cells. , 1993, The Journal of clinical investigation.

[25]  D. C. Han,et al.  Effects of delayed treatment with enalapril and/or lovastatin on the progression of glomerulosclerosis in 5/6 nephrectomized rats. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  R. Volkmann,et al.  Beneficial effect of captopril on systemic lupus erythematosus-like disease in MRL lpr/lpr mice. , 1988, International archives of allergy and applied immunology.

[27]  A. Theofilopoulos,et al.  Etiopathogenesis of murine SLE. , 1981, Immunological reviews.